Sequase XR 50 mg
Sequase XR 50 mg is a medicine authorised by Swissmedic under authorisation number 63255. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 October 2013 and the authorisation is valid without a time limit. ATC code N05AH04 places the medicine in the group Psycholeptics.
| Authorisation number | 63255 |
|---|---|
| Name | Sequase XR 50 mg |
| Full name | Sequase XR 50 mg, Retardtabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AH04 |
| First authorisation | 01 October 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sequase XR 50 mg, Retardtabletten | B | 01 October 2013 |
| 2 | Sequase XR 150 mg, Retardtabletten | B | 01 October 2013 |
| 3 | Sequase XR 200 mg, Retardtabletten | B | 01 October 2013 |
| 4 | Sequase XR 300 mg, Retardtabletten | B | 01 October 2013 |
| 5 | Sequase XR 400 mg, Retardtabletten | B | 01 October 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 2 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 3 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 4 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 5 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 6 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 7 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 8 | 60 | Tablette(n) | N05AH04 | 01.05.0. | B |
| 9 | 100 | Tablette(n) | N05AH04 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sequase XR 50 mg authorised in Switzerland?
Yes. Sequase XR 50 mg is authorised by Swissmedic under authorisation number 63255, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sequase XR 50 mg have?
Sequase XR 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sequase XR 50 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.